Comment

Families USA Submits Comment Letter on Notice of Benefit and Payment Parameters (NBPP) Proposed Rule

Families USA submitted comments on the Centers for Medicare and Medicaid Services (CMS) 2027 Notice of Benefit and Payment Parameters (NBPP) proposed rule. Many of the policies proposed in the 2027 NB...

Families USA Submits Testimony in Support of LD 2196 to Lower Health Insurance Costs and Reduce Barriers to Care

On March 5, 2026, Sophia Tripoli, Senior Director of Health Policy at Families USA, submitted written testimony to the Maine Joint Standing Committee on Health and Human Services, in support of LD 21...

Families USA Submits Comment Letter on Proposed Transparency in Coverage (TiC) Rule

Families USA, on behalf of the Consumers First steering committee, submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed Transparency in Coverage (TiC) rule. Consumers...

Families USA Comment on GUARD Drug Pricing Model

Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to...

Families USA Submits Comment Letter on Proposed Rule Blocking Access to Gender-Affirming Care

Families USA submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule Medicare and Medicaid Programs; Hospital Conditions of Participation: Limiting Participation Bas...

Families USA Submits Testimony Expressing Support for the Fair Pricing Act

On February 10th, 2026, Families USA submitted written testimony to the New York State Joint Legislative Budget Hearing on Health, expressing support for the Fair Pricing Act (S. 705/A. 2140). ...

Families USA Statement for the Record for Energy and Commerce’s Health Subcommittee Hearing on Lowering Health Care Costs on Prescription Drugs

Families USA submitted a statement on the Energy and Commerce Health Subcommittee outlining how big drug companies and Pharmacy Benefit Managers (PBM) are driving up the cost of prescription drugs. ...